Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-04-22

Clinical Trial Update: Assessment of the Effect of Captopril Versus Combination of Captopril and Pentoxifylline on Reducing Proteinuria in Type 2 Diabetic Nephropathy [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update reports a comparison of captopril alone versus captopril plus pentoxifylline for reducing proteinuria in diabetic nephropathy, spanni…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Capoten (captopril)
  • Trental (pentoxifylline)

Snippet

Sponsor: Shiraz University of Medical Sciences | Conditions: Diabetic Nephropathy | Phase 2, Phase 3 | Status: COMPLETED